Abattis Bioceuticals Corp.
ATTBF
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.33K
Close$
Share Statistics
| Market cap | $14,334.00 |
|---|---|
| Enterprise Value | $-435,505.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | -47.79 |
| Outstanding Shares | 477,884,481 |
Return
| Return on Equity | -27.46% |
|---|---|
| Return on Assets | -15.79% |
| Return on Invested Capital | -27.28% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.22 |
| Enterprise Value to EBIT | 0.11 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -3.6 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Abattis Bioceuticals Corp.
CEO: Robert Abenante Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. It produces, markets, and licenses proprieta...